Supreme Court Rejects Most Pharma Cases This Term, But Patent Settlements Stir Interest
High court seeks Solicitor General's view on whether patent settlements blocking authorized generics are anticompetitive; court denies GSK petition challenging payer claims in Avandia litigation.